Search Result "PAC1"
Targeting the PAC1 Receptor for Neurological and Metabolic Disorders
Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 16 Year: 2019 Page: 1399-1417
Author(s): Chenyi Liao,Mathilde P. de Molliens,Severin T. Schneebeli,Matthias Brewer,Gaojie Song,David Chatenet,Karen M. Braas,Victor May,Jianing Li
Pituitary Adenylate Cyclase-Activating Polypeptide: Focus on Structure- Activity Relationships of a Neuroprotective Peptide
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 3 Year: 2009 Page: 4462-4480
Author(s): S. Bourgault, D. Vaudry, A. Dejda, N. D. Doan, H. Vaudry, A. Fournier
Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 3 Year: 2011 Page: 204-214
Author(s): Tommy Seaborn, Olfa Masmoudi-Kouli, Alain Fournier, Hubert Vaudry, David Vaudry
Review on the Protective Effects of PACAP in Models of Neurodegenerative Diseases In Vitro and In Vivo
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 1 Year: 2011 Page: 962-972
Author(s): D. Reglodi, P. Kiss, A. Lubics, A. Tamas
Therapeutic Potential of Vasoactive Intestinal Peptide and its Receptors in Neurological Disorders
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 5 Year: 2010 Page: 661-666
Author(s): Caitlin M. White, Sunggoan Ji, Huan Cai, Stuart Maudsley, Bronwen Martin
Alpha-Secretase As a Therapeutic Target
Journal: Current Alzheimer Research
Volume: 4 Issue: 4 Year: 2007 Page: 412-417
Author(s): Falk Fahrenholz
PACAP and Its Receptors Exert Pleiotropic Effects in The Nervous System by Activating Multiple Signaling Pathways
Journal: Current Protein & Peptide Science
Volume: 3 Issue: 4 Year: 2002 Page: 423-439
Author(s): Cheng-Ji Zhou, Seiji Shioda, Toshihiko Yada, Nobuya Inagaki, Samuel J. Pleasure, Sakae Kikuyama
How the Protein Architecture of RNases III Influences their Substrate Specificity?
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 33 Year: 2016 Page: 5065-5071
Author(s): Guillermin Agüero-Chapin,Gisselle Pérez-Machado,Juan Collà Mull,Evys Ancede-Gallardo,Agostinho Antunes,Gustavo A. de la Riva de la Riva
Clinical Potential of VIP by Modified Pharmaco-kinetics and Delivery Mechanisms
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 12 Issue: 4 Year: 2012 Page: 344-350
Author(s): Bernhard Burian,Anna Ortner,Ruth Prassl,Andreas Zimmer,Wilhelm Mosgoeller
Vasoactive Intestinal Peptide Receptors: A Molecular Target in Breast and Lung Cancer
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 1 Year: 2007 Page: 1099-1104
Author(s): Terry W. Moody, Illana Gozes